Bionano Genomics Inc (BNGO) |
|
8.55 -0.93 (-9.81%)
|
03-03 16:57 |
|
Open: |
9.57 |
Pre. Close: |
9.48 |
|
High:
|
9.59 |
Low:
|
8.45 |
|
Volume:
|
27,039,535 |
Market Cap:
|
2,324M |
|
|
|
|
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The company is headquartered in San Diego, California and currently employs 77 full-time employees. The firm develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.609 - 9.663 |
9.663 - 9.722 |
|
Low:
|
8.312 - 8.367 |
8.367 - 8.426 |
|
Close:
|
8.447 - 8.542 |
8.542 - 8.646 |
|
Technical analysis |
as of: 2021-03-03 4:37:11 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 14.92 One year: 18.33 |
| Support: |
Support1: 8.05 Support2: 6.70 |
| Resistance: |
Resistance1: 12.77 Resistance2: 15.69 |
| Pivot: |
11.61  |
| Moving Average: |
MA(5): 9.52 MA(20): 11.58
MA(100): 4.43  MA(250): 2.09 |
| MACD: |
MACD(12,26): 0.15 Signal(9): 0.86 |
| Stochastic oscillator: |
%K(14,3): 16.23 %D(3): 20.45 |
| RSI: |
RSI(14): 41.89 |
| 52-week: |
High: 15.69 Low: 0.25 Change(%): 656.6 |
| Average Vol(K): |
3-Month: 8947078 10-Days: 2693384 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.BNGO has closed above bottom band by 11.5%. Bollinger Bands are 156.5% wider than normal. The large width of the bands suggest high volatility as compared to BNGO's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 03 Mar 2021
BioNano Genomics, Inc. (BNGO) Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr - StreetInsider.com
Wed, 03 Mar 2021
Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr - Yahoo Finance
Tue, 02 Mar 2021
Bionano Genomics Would Have Been a Great Find Months Ago - InvestorPlace
Mon, 01 Mar 2021
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know - Yahoo Finance
Mon, 01 Mar 2021
Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and Cancer - Yahoo Finance
Mon, 01 Mar 2021
Bionano Genomics' Second Chance - Seeking Alpha
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
272 |
| Shares Float (M) |
152 |
|
% Held by Insiders
|
0.06 |
|
% Held by Institutions
|
5.64 |
|
Shares Short (K)
|
25,470 |
|
Shares Short P. Month (K)
|
8,480 |
Stock Financials |
|
EPS
|
-0.520 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.100 |
|
Profit Margin
|
|
|
Operating Margin
|
-453.08 |
|
Return on Assets (ttm)
|
-68.2 |
|
Return on Equity (ttm)
|
-1021.6 |
|
Qtrly Rev. Growth
|
-33.7 |
|
Gross Profit (p.s.)
|
0.012 |
|
Sales Per Share
|
0.027 |
|
EBITDA (p.s.)
|
-0.117 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-36 |
|
Levered Free Cash Flow (M)
|
-16 |
Stock Valuations |
|
PE Ratio
|
-16.44 |
|
PEG Ratio
|
|
|
Price to Book value
|
85.50 |
|
Price to Sales
|
318.38 |
|
Price to Cash Flow
|
-65.30 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
